메뉴 건너뛰기




Volumn 1102, Issue , 2014, Pages 513-522

Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients

Author keywords

Circulating tumor cells; CTC; Melanoma; Quantitative real time RT PCR

Indexed keywords

BCG VACCINE; BIOLOGICAL MARKER; MELAN A; MELANOMA ANTIGEN 3; MELANOMA VACCINE; MESSENGER RNA; TRANSCRIPTION FACTOR PAX3;

EID: 84891752581     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-727-3_27     Document Type: Article
Times cited : (10)

References (12)
  • 1
    • 74949143594 scopus 로고    scopus 로고
    • Final version of 2009 AJCC melanoma staging and classification
    • Balch CM, Gershenwald JE, Soong SJ et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27(36):6199-6206
    • (2009) J Clin Oncol , vol.27 , Issue.36 , pp. 6199-6206
    • Balch, C.M.1    Gershenwald, J.E.2    Soong, S.J.3
  • 3
    • 84862806703 scopus 로고    scopus 로고
    • Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma
    • Hoshimoto S, Faries MB, Morton DL et al (2011) Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma. Ann Surg 255(2): 357-362
    • (2011) Ann Surg , vol.255 , Issue.2 , pp. 357-362
    • Hoshimoto, S.1    Faries, M.B.2    Morton, D.L.3
  • 4
    • 32944480188 scopus 로고    scopus 로고
    • Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: Outcome prediction in a multicenter trial
    • Koyanagi K, O'Day SJ, Gonzalez R et al (2005) Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: Outcome prediction in a multicenter trial. J Clin Oncol 23(31):8057-8064
    • (2005) J Clin Oncol , vol.23 , Issue.31 , pp. 8057-8064
    • Koyanagi, K.1    O'Day, S.J.2    Gonzalez, R.3
  • 5
    • 0034655139 scopus 로고    scopus 로고
    • Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence
    • Hoon DS, Bostick P, Kuo C et al (2000) Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res 60(8):2253-2257
    • (2000) Cancer Res , vol.60 , Issue.8 , pp. 2253-2257
    • Hoon, D.S.1    Bostick, P.2    Kuo, C.3
  • 6
    • 78751622090 scopus 로고    scopus 로고
    • Molecular upstaging based on paraffi nembedded sentinel lymph nodes: Ten-year follow-up confi rms prognostic utility in melanoma patients
    • Nicholl MB, Elashoff D, Takeuchi H et al (2010) Molecular upstaging based on paraffi nembedded sentinel lymph nodes: Ten-year follow-up confi rms prognostic utility in melanoma patients. Ann Surg 253(1):116-122
    • (2010) Ann Surg , vol.253 , Issue.1 , pp. 116-122
    • Nicholl, M.B.1    Elashoff, D.2    Takeuchi, H.3
  • 7
    • 4344590283 scopus 로고    scopus 로고
    • Prognostic significance of molecular upstaging of paraffi n-embedded sentinel lymph nodes in melanoma patients
    • Takeuchi H, Morton DL, Kuo C et al (2004) Prognostic significance of molecular upstaging of paraffi n-embedded sentinel lymph nodes in melanoma patients. J Clin Oncol 22(13):2671-2680
    • (2004) J Clin Oncol , vol.22 , Issue.13 , pp. 2671-2680
    • Takeuchi, H.1    Morton, D.L.2    Kuo, C.3
  • 8
    • 77950968549 scopus 로고    scopus 로고
    • Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma
    • Koyanagi K, O'Day SJ, Boasberg P et al (2010) Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma. Clin Cancer Res 16(8): 2402-2408
    • (2010) Clin Cancer Res , vol.16 , Issue.8 , pp. 2402-2408
    • Koyanagi, K.1    O'Day, S.J.2    Boasberg, P.3
  • 9
    • 33748068119 scopus 로고    scopus 로고
    • The prognostic value of circulating tumor cells in patients with melanoma: A systematic review and meta-analysis
    • Mocellin S, Hoon D, Ambrosi A et al (2006) The prognostic value of circulating tumor cells in patients with melanoma: A systematic review and meta-analysis. Clin Cancer Res 12(15): 4605-4613
    • (2006) Clin Cancer Res , vol.12 , Issue.15 , pp. 4605-4613
    • Mocellin, S.1    Hoon, D.2    Ambrosi, A.3
  • 10
    • 4143094988 scopus 로고    scopus 로고
    • Circulating tumor cells, disease progression, and survival in metastatic breast cancer
    • Cristofanilli M, Budd GT, Ellis MJ et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8):781-791
    • (2004) N Engl J Med , vol.351 , Issue.8 , pp. 781-791
    • Cristofanilli, M.1    Budd, G.T.2    Ellis, M.J.3
  • 11
    • 64149093514 scopus 로고    scopus 로고
    • MRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanomaassociated antigen-specific monoclonal antibody beads
    • Kitago M, Koyanagi K, Nakamura T et al (2009) mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanomaassociated antigen-specific monoclonal antibody beads. Clin Chem 55(4):757-764
    • (2009) Clin Chem , vol.55 , Issue.4 , pp. 757-764
    • Kitago, M.1    Koyanagi, K.2    Nakamura, T.3
  • 12
    • 21144449188 scopus 로고    scopus 로고
    • Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: Relation to disease stage in melanoma patients
    • Koyanagi K, Kuo C, Nakagawa T et al (2005) Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: Relation to disease stage in melanoma patients. Clin Chem 51(6):981-988
    • (2005) Clin Chem , vol.51 , Issue.6 , pp. 981-988
    • Koyanagi, K.1    Kuo, C.2    Nakagawa, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.